Caina Technology Co

Caina Technology Co Net Tangible Assets

The Net Tangible Assets of Caina Technology Co (301122.SZ) as of Nov 14, 2026 is 1.84 B CNY. In the previous year, Net Tangible Assets was 1.76 B CNY — a change of 4.55% (higher).

Net Tangible Assets

1.84 BCNY

YoY

4.55%

Last updated:

Net Tangible Assets of Caina Technology Co is 2025 1.84 B CNY. Net Tangible Assets of Caina Technology Co was 2024 1.76 B CNY. It decreases by 4.55% higher compared to the previous year.

The Caina Technology Co Net Tangible Assets history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Net Tangible Assets
Date
Net Tangible Assets
Jan 1, 2018
90.40 M CNY
Jan 1, 2019
123.38 M CNY
Jan 1, 2020
330.37 M CNY
Jan 1, 2021
466.93 M CNY
Jan 1, 2022
1.69 B CNY
Jan 1, 2023
1.76 B CNY
Jan 1, 2024
1.76 B CNY
Jan 1, 2025
1.84 B CNY
The Caina Technology Co Net Tangible Assets history
YEARNet Tangible AssetsYoY
1.84 BCNY+4.55%
1.76 BCNY-0.29%
1.76 BCNY+4.15%
1.69 BCNY+262.77%
466.93 MCNY+41.34%
330.37 MCNY+167.76%
123.38 MCNY+36.49%
90.40 MCNY-0.31%
90.68 MCNY—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Caina Technology Co Stock analysis

What does Caina Technology Co do? Caina Technology Co., Ltd. manufactures medical consumables including puncture needles, syringes, laboratory consumables, and masks. The company's main products are reusable copper base injection needles, aluminum base injection needles, disposable aluminum-plastic inlaid injection needles, safety blood collection needles, sheathed syringes, disposable Sterile syringes, petri dishes, and reagent tubes. Caina Technology exports its products to the United States, the United Kingdom, and the European Union, serving international markets with its medical supplies. The company generates revenue through the sale of its medical consumables to global healthcare providers and distributors. Its product range targets hospitals, clinics, and laboratories requiring reliable medical equipment. Caina Technology's focus on exporting to developed markets ensures steady demand for its high-quality, compliant medical products. Caina Technology's business model relies on manufacturing and exporting medical consumables to international customers. The firm's product portfolio includes specialized items like safety blood collection needles and sterile syringes, which are essential for healthcare facilities. By targeting key regions such as the United States, United Kingdom, and European Union, the company secures consistent sales channels for its medical supplies. Caina Technology Co is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Caina Technology Co stock

Net Tangible Assets of Caina Technology Co is 1.84 B CNY in 2025.

Net Tangible Assets of Caina Technology Co changed from 1.76 B CNY to 1.84 B CNY, representing a 4.55% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of Net Tangible Assets Caina Technology Co since 2006 – with annual values, charts, and detailed analysis.

Net tangible assets equal total assets minus intangible assets, goodwill, and liabilities. They represent the physical asset backing of a company.

Net Tangible Assets's CNY is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track Net Tangible Assets's Caina Technology Co historically and in real time.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Balance Sheet — Caina Technology Co

All Key Metrics — Caina Technology Co